Unknown PHASE1 INTERVENTIONAL 4-arm NCT05730062

Influence of Oxycodone on Individuals Taking an SSRI (OXIS)

Sponsor: Leiden University Medical Center

Conditions Anxiety Disorders Depressive Disorder Opioid Induced Respiratory Depression

Interventions Oxycodone Hydrochloride Placebo

Updated 4 times since 2023 Last updated: Feb 14, 2023 Started: Mar 15, 2023 Primary completion: Jan 15, 2025 Completion: Apr 15, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05730062, this PHASE1 trial focuses on Anxiety Disorders and Depressive Disorder and remains ongoing. Sponsored by Leiden University Medical Center, it has been updated 4 times since 2023, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

4 versions recorded

May 2025 — Present [monthly]

Unknown PHASE1

Status: Not Yet Recruiting → Unknown
Sep 2024 — May 2025 [monthly]

Not Yet Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE1
Mar 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Leiden University Medical Center

Data source: Leiden University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.